All the first 5 authors of #orbita2 are UK cardiology fellows which could only have been possible under the exceptional mentorship, supervision and drive of Rasha Al-Lamee. I feel deeply humbled and proud to have been part of this incredible team!
#AHA23 BCIS
BJCA 📊 European Society of Cardiology
#CoronaryPhysiology
#IntravascularImaging
#EuroPCR 2024
#LateBreakingscience
BUSY E U R O P C R 🇫🇷
🔥 Diffuse vs focal
🔥 MRR in STEMI
🔥 FAME 3 CABG vs PCI cost
🔥 ORBITA2 symptoms
🔥 REVIVED-BCIS complete revasc
🔥 CALIPSO OCT calcium
🔥 Angio-based FFR
…
👇
Excellent deep dive with #orbita2 happening now #AHA23 with Christopher Rajkumar Rasha Al-Lamee Dipti Itchhaporia, M.D., MACC , FAHA, FESC.
Remember, all 301 angiograms are published in the supplementary appendix (as done in the first ORBITA so you can see for yourself). Median FFR=0.63, iFR=0.78 at randomisation
Brilliant Mass General Heart Grand Rounds by Rasha Al-Lamee on placebo-controlled trials for medical procedures. Will be looking forward to ORBITA2, ORBITA-STAR, and ORBITA-COSMIC
Special day at Essex CTC today. ORBITA2 randomisation in lab 1 and simultaneously ORBITA CTO randomisation in cath lab 2. We are getting good at placebo controlled pci ! Can’t wait for both trial results. Rasha Al-Lamee Chris Cook Christopher Rajkumar Dr S Khan Essex Heart Fund
Just 8 days until we present the results of the placebo-controlled #ORBITA2 trial as late breaking science at #AHA23 in Philadelphia. Join us at 10:35 ET on Saturday 11/11/23. Rasha Al-Lamee Matthew Shun-Shin Prof Darrel Francis ☺ Mk CardioFellows Great Again American Heart Association